Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Asset Utilization Ratio (2021 - 2022)

Historic Asset Utilization Ratio for Immuneering (IMRX) over the last 3 years, with Q3 2023 value amounting to 0.0.

  • Immuneering's Asset Utilization Ratio fell 9989.62% to 0.0 in Q3 2023 from the same period last year, while for Sep 2023 it was 0.0, marking a year-over-year decrease of 9989.62%. This contributed to the annual value of 0.0 for FY2022, which is 8918.67% down from last year.
  • Per Immuneering's latest filing, its Asset Utilization Ratio stood at 0.0 for Q3 2023, which was down 9989.62% from 0.0 recorded in Q2 2023.
  • Immuneering's Asset Utilization Ratio's 5-year high stood at 0.02 during Q3 2021, with a 5-year trough of 0.0 in Q3 2023.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.0 (2022), whereas its average is 0.01.
  • As far as peak fluctuations go, Immuneering's Asset Utilization Ratio crashed by 8031.68% in 2022, and later plummeted by 9989.62% in 2023.
  • Over the past 3 years, Immuneering's Asset Utilization Ratio (Quarter) stood at 0.01 in 2021, then crashed by 80.32% to 0.0 in 2022, then crashed by 99.85% to 0.0 in 2023.
  • Its Asset Utilization Ratio stands at 0.0 for Q3 2023, versus 0.0 for Q2 2023 and 0.0 for Q1 2023.